Qsemble Capital Management LP Makes New $2.08 Million Investment in Cigna Group $CI

Qsemble Capital Management LP purchased a new stake in shares of Cigna Group (NYSE:CI) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 7,559 shares of the health services provider’s stock, valued at approximately $2,084,000.

Other hedge funds also recently bought and sold shares of the company. Wilkerson Advisory Group LLC bought a new stake in Cigna Group during the 4th quarter valued at about $25,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Cigna Group during the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc bought a new stake in shares of Cigna Group during the fourth quarter valued at approximately $29,000. Cedar Mountain Advisors LLC lifted its position in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares in the last quarter. Finally, Creative Financial Designs Inc. ADV boosted its stake in Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 81 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of CI opened at $282.24 on Friday. The firm has a fifty day simple moving average of $286.02 and a two-hundred day simple moving average of $281.28. The firm has a market cap of $74.58 billion, a PE ratio of 11.68, a P/E/G ratio of 0.96 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period last year, the business posted $7.20 EPS. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts anticipate that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is currently 25.82%.

Insider Activity

In other news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CI. Royal Bank Of Canada boosted their price target on Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research note on Friday, May 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. The Goldman Sachs Group boosted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Mizuho upped their target price on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research note on Monday, June 8th. Finally, UBS Group raised their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $339.45.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.